Published in Cancer Res on May 15, 1989
Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest (1996) 2.97
Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development (1996) 2.88
Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol (1991) 2.38
Urokinase type plasminogen activator receptor expression in colorectal neoplasms. Gut (1998) 1.50
The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1. Mol Cell Biol (1990) 1.49
Transforming growth factor beta 1-responsive element: closely associated binding sites for USF and CCAAT-binding transcription factor-nuclear factor I in the type 1 plasminogen activator inhibitor gene. Mol Cell Biol (1992) 1.32
In situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol (1990) 1.31
Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells. Clin Exp Metastasis (1998) 1.15
Control of junB and extracellular matrix protein expression by transforming growth factor-beta 1 is independent of simian virus 40 T antigen-sensitive growth-sensitive growth-inhibitory events. Mol Cell Biol (1991) 1.10
Vacuum Assisted Closure Therapy versus Standard Wound Therapy for Open Musculoskeletal Injuries. Adv Orthop (2013) 1.09
The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃. Best Pract Res Clin Endocrinol Metab (2011) 1.02
Expression of transforming growth factor-alpha in primary human colon and lung carcinomas. Br J Cancer (1990) 1.02
Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am J Pathol (1995) 0.99
Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells. EMBO J (1991) 0.99
Plasminogen activation in healing human wounds. Am J Pathol (1994) 0.95
Prognostic role of urokinase-type plasminogen activator in human gliomas. Am J Pathol (1995) 0.91
Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor. Br J Cancer (2000) 0.89
p52(PAI-1) and actin expression in butyrate-induced flat revertants of v-ras-transformed rat kidney cells. Biochem J (1991) 0.89
Plasmin cleaves betaglycan and releases a 60 kDa transforming growth factor-beta complex from the cell surface. Biochem J (1994) 0.87
Urine and serum free IGF-1 levels in patients with bladder cancer: a brief report. Urol Res (2003) 0.85
Cross-linked telopeptides of type I and III collagens in malignant ovarian tumours in vivo. Br J Cancer (1999) 0.84
Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes. Proc Natl Acad Sci U S A (1991) 0.83
P52PAI-1 gene expression in butyrate-induced flat revertants of v-ras-transformed rat kidney cells: mechanism of induction and involvement in the morphological response. Biochem J (1997) 0.82
Adiponectin receptors are downregulated in human gastric cancer. J Gastroenterol (2010) 0.82
Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma. Am J Pathol (1995) 0.82
Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture. Acta Neuropathol (1992) 0.80
Complex regulation of plasminogen activator inhibitor type-1 (PAI-1) gene expression by serum and substrate adhesion. Biochem J (1996) 0.79
Expression of serine proteinases and metalloproteinases in organ-cultured human skin. Altered levels in the presence of retinoic acid and possible relationship to retinoid-induced loss of epidermal cohesion. Am J Pathol (1994) 0.78
Separation, purification and N-terminal sequence analysis of a novel leupeptin-sensitive serine endopeptidase present in chemically induced rat mammary tumour. Biochem J (1992) 0.78
Cell-shape-dependent modulation of p52(PAI-1) gene expression involves a secondary response pathway. Biochem J (1995) 0.78
The effects of continuous exposure to epidermal growth factor on the spontaneous transformation of cultured rat liver epithelial cells. Am J Pathol (1992) 0.77
Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1. Proc Natl Acad Sci U S A (1997) 0.77
The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells. Cell Regul (1991) 0.76
Role of Expression of Inflammatory Mediators in Primary and Recurrent Lumbar Disc Herniation. J Korean Neurosurg Soc (2016) 0.75
Regulation of the plasminogen activator system in non-small cell lung cancer cell lines by growth factors EGF, TGF-alpha and TGF-beta. Br J Cancer (1992) 0.75
Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients. Br J Cancer (1994) 0.75
Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med (1987) 4.35
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol (1988) 4.34
Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest (1987) 2.74
Growth factors in the extracellular matrix. FASEB J (1997) 2.71
Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol (1986) 2.44
Latent transforming growth factor-beta binding proteins (LTBPs)--structural extracellular matrix proteins for targeting TGF-beta action. Cytokine Growth Factor Rev (1999) 2.22
Dimeric character of fibronectin, a major cell surface-associated glycoprotein. Biochem Biophys Res Commun (1977) 2.18
Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol (1994) 2.15
Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment. J Exp Med (1981) 2.10
Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. J Biol Chem (1987) 2.05
Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta. Mol Biol Cell (2000) 2.01
Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci U S A (2001) 1.83
Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem (1996) 1.79
Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med (1989) 1.77
Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation. Mol Cell Biol (1989) 1.70
Latency, activation, and binding proteins of TGF-beta. Microsc Res Tech (2001) 1.70
Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. J Biol Chem (1991) 1.68
Transforming growth factors and control of neoplastic cell growth. J Cell Biochem (1987) 1.67
Cross-linking of a major fibroblast surface-associated glycoprotein (fibronectin) catalyzed by blood coagulation factor XIII. Cell (1976) 1.64
Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem (1995) 1.61
Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J Biol Chem (1992) 1.50
Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1. EMBO J (1996) 1.50
Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem J (1998) 1.48
Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. Adv Cancer Res (1998) 1.48
Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer (1999) 1.38
Impaired migration and delayed differentiation of pancreatic islet cells in mice lacking EGF-receptors. Development (2000) 1.38
Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene. Gene (2000) 1.37
Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain. J Biol Chem (2000) 1.36
The cellular response to induction of the p21 c-Ha-ras oncoprotein includes stimulation of jun gene expression. EMBO J (1989) 1.35
Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem (1996) 1.35
Transforming growth factor beta alters plasminogen activator activity in human skin fibroblasts. Exp Cell Res (1986) 1.32
Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells--role in metastasis. Int J Cancer (1982) 1.31
Murine sarcoma growth factors affect the growth and morphology of cultured mouse epithelial cells. J Cell Physiol (1980) 1.30
Direct association of fibronectin and actin molecules in vitro. J Cell Biol (1980) 1.28
Identification and characterization of a new latent transforming growth factor-beta-binding protein, LTBP-4. J Biol Chem (1998) 1.24
Fibroblast surface antigen (SF): molecular properties, distribution in vitro and in vivo, and altered expression in transformed cells. J Supramol Struct (1976) 1.23
Latent TGF-beta binding protein LTBP-1 contains three potential extracellular matrix interacting domains. J Cell Sci (2001) 1.23
Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. FASEB J (2001) 1.22
Interaction of viral envelope glycoproteins with fibronectin. Infect Immun (1983) 1.21
Transforming growth factor beta regulation of cell proliferation. J Cell Physiol Suppl (1987) 1.18
Distribution of a major surface-associated glycoprotein, fibronectin, in cultures of adherent cells. J Supramol Struct (1977) 1.18
1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ (2000) 1.14
Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin. J Cell Biochem (1992) 1.12
Independent promoters regulate the expression of two amino terminally distinct forms of latent transforming growth factor-beta binding protein-1 (LTBP-1) in a cell type-specific manner. J Biol Chem (1999) 1.12
The cellular target for the plasminogen activator, urokinase, in human fibroblasts - 66 000 dalton protein. Biochim Biophys Acta (1982) 1.09
Dose effects of transfected c-Ha-rasVal 12 oncogene in transformed cell clones. Exp Cell Res (1987) 1.04
Pachydermoperiostosis: analysis of the connective tissue abnormality in one family. J Am Acad Dermatol (1994) 1.04
Gremlin localization and expression levels partially differentiate idiopathic interstitial pneumonia severity and subtype. J Pathol (2008) 1.02
Calcium ionophores decrease pericellular gelatinolytic activity via inhibition of 92-kDa gelatinase expression and decrease of 72-kDa gelatinase activation. J Biol Chem (1995) 1.01
Interaction of fibronectin with complement component C3. Scand J Immunol (1983) 1.01
Extracellular matrix proteins characterize human tumor cell lines. Int J Cancer (1981) 1.00
Promoter characterization of the human and mouse epilysin (MMP-28) genes. Gene (2001) 0.96
Isolation of an actin-binding fragment of fibronectin. Biochem J (1981) 0.95
Rapid membrane changes in mouse epithelial cells after exposure to epidermal growth factor. J Ultrastruct Res (1981) 0.94
Cutis laxa in hereditary gelsolin amyloidosis. Br J Dermatol (2005) 0.93
Recombinant latent transforming growth factor beta-binding protein 2 assembles to fibroblast extracellular matrix and is susceptible to proteolytic processing and release. J Biol Chem (1998) 0.93
Keratin filaments of mouse epithelial cells are rapidly affected by epidermal growth factor. J Cell Biol (1981) 0.92
Fibronectin and the pericellular matrix of normal and transformed adherent cells. Ann N Y Acad Sci (1978) 0.91
Fibroblast surface antigen (SF): the external glycoprotein lost in proteolytic stimulation and maligant transfromation. Int J Cancer (1976) 0.91
Ovarian thecal cells produce transforming growth factor-beta which can regulate granulosa cell growth. Endocrinology (1987) 0.90
Affinity of myeloma IgG proteins for fibronectin. Clin Exp Immunol (1983) 0.90
Transforming growth factor beta 1 and its latent form binding protein-1 associate with elastic fibres in human dermis: accumulation in actinic damage and absence in anetoderma. Br J Dermatol (1997) 0.90
1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells. Cancer Res (1995) 0.90
Transforming growth factors-beta as regulators of cellular growth and phenotype. Crit Rev Oncog (1992) 0.89
Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells. Cancer Res (2001) 0.89
Hepatocyte growth factor releases epithelial and endothelial cells from growth arrest induced by transforming growth factor-beta1. J Biol Chem (1996) 0.88
Thrombin affects fibronectin and procollagen in the pericellular matrix of cultured human fibroblasts. Biochim Biophys Acta (1981) 0.88
Acute myelogenous leukaemia with c-myc amplification and double minute chromosomes. Lancet (1985) 0.86
Okadaic acid-elicited transcriptional activation of collagenase gene expression in HT-1080 fibrosarcoma cells is mediated by JunB. Cell Growth Differ (1994) 0.86
Establishment and characterization of the epithelial mouse embryo cell line MMC-E. Cancer Res (1979) 0.86
TGF-beta 1 modulation of urokinase and PAI-1 expression in human bronchial epithelial cells. Am J Physiol (1990) 0.86
Epidermal growth factor-induced alterations in proliferating mouse epithelial cells. Exp Cell Res (1980) 0.85
Truncal telangiectases coinciding with felodipine. Dermatology (1998) 0.85
Novel non-TGF-beta-binding splice variant of LTBP-4 in human cells and tissues provides means to decrease TGF-beta deposition. J Cell Sci (2001) 0.85
Localization of viral-envelope-glycoprotein-binding sites in fibronectin. Biochem J (1984) 0.84
C3c and C3d fragments of human C3 bind myeloma IgG1 and IgG3 proteins. Immunol Lett (1982) 0.84
Induction of transforming growth factor beta 1 and its receptor expression during myeloid leukemia cell differentiation. Cell Growth Differ (1994) 0.82
Rapid release of fibronectin from human lung fibroblasts by biologically active phorbol esters. Int J Cancer (1979) 0.82
Specific effects of fibronectin-releasing peptides on the extracellular matrices of cultured human fibroblasts. Cancer Res (1980) 0.82
Cerebrospinal fluid IgG bands and virus-specific IgG, IgM, and IgA antibodies in herpes simplex virus encephalitis. J Neuroimmunol (1982) 0.82
Structure and expression of type IV collagenase genes. Cell Differ Dev (1990) 0.82
Growth inhibitory polypeptides in the regulation of cell proliferation. Med Biol (1987) 0.81
Cyclosporin A enhances cytokine and phorbol ester-induced fibroblast collagenase expression. J Invest Dermatol (1994) 0.81
Transformation of MMC-E epithelial cells by acute 3611-MSV: inhibition of collagen synthesis and induction of novel polypeptides. J Cell Biochem (1982) 0.81
Enhancement of vitronectin expression in human HepG2 hepatoma cells by transforming growth factor-beta 1. Eur J Biochem (1991) 0.81
Vitamin D3 regulation of transforming growth factor-beta system in epithelial and fibroblastic cells--relationships to plasminogen activation. J Investig Dermatol Symp Proc (1996) 0.81
Apoptosis of human endothelial cells is accompanied by proteolytic processing of latent TGF-beta binding proteins and activation of TGF-beta. Cell Death Differ (2005) 0.81
Loss of different pericellular matrix components of rat cells transformed with a T-class ts mutant of Rous sarcoma virus. Virology (1982) 0.80
Transforming growth factor-beta system and its regulation by members of the steroid-thyroid hormone superfamily. Adv Cancer Res (1996) 0.80
Polymerization of a major surface-associated glycoprotein, fibronectin, in cultured fibroblasts. FEBS Lett (1976) 0.80
Hepatocyte growth factor releases mink epithelial cells from transforming growth factor beta1-induced growth arrest by restoring Cdk6 expression and cyclin E-associated Cdk2 activity. Mol Cell Biol (1999) 0.80
Effects of Zn2+ ions on protein phosphorylation in epithelial cell membranes. J Cell Physiol (1983) 0.80
Regulation of plasminogen activator activity in human fibroblastic cells by fibrosarcoma cell-derived factors. Cancer Res (1985) 0.79
Growth control in chick embryo fibroblasts; no evidence for a specific role for cyclic purine nucleotides. Cell (1974) 0.79
Vitamin D receptor polymorphism and treatment of psoriasis with calcipotriol. Br J Dermatol (1997) 0.79
Binding of fibronectin to actin is inhibited by gelatin. Biochem Biophys Res Commun (1981) 0.79
Down-regulation of transforming growth factor-beta receptors I and II is seen in lesional but not non-lesional psoriatic epidermis. Br J Dermatol (1998) 0.79
Vitamin D3 and calcipotriol enhance the secretion of transforming growth factor-beta 1 and -beta 2 in cultured murine keratinocytes. Growth Factors (1993) 0.78